Overcoming time pressure and the global shortage of test kits and reagents, the 8-member Microbiology team from Gleneagles Hospital Hong Kong’s Clinical Laboratory has made in-house COVID-19 testing a reality, about two months after Hong Kong confirmed its first COVID-19 case.
Today, Gleneagles Hospital Hong Kong is capable of testing up to 150 COVID-19 samples daily in its laboratory. It uses two test platforms (POCT or point of care testing and PCR or polymerase chain reaction testing), to provide quality and efficient service to meet our patients’ needs.
Between end of March and end of May, the hospital tested more than 200 cases, while supporting the Hong Kong Government Department of Health’s Community Deep Throat Saliva Surveillance Programme with about 300 cases.
The team is ramping up the laboratory’s testing capacity to meet the anticipated surge in testing demand as the government prepares to open up its borders to businesses travellers with negative COVID-19 nucleic acid testing result certification.
By making COVID-19 testing available to our patients and the medical needs of our clinicians, Gleneagles Hospital Hong Kong is helping to stem the spread of the virus in the community. It is also keeping our hospital safe for our inpatients and frontline staff, ensuring that it continues to provide uninterrupted healthcare services during the COVID-19 pandemic.
Related Stories
IHH Healthcare Deepens Commitment to Reduce Cancer Burden in Malaysia
Learn how our third memorandum of understanding with Ministry of Health Malaysia is expanding access to life-saving, advanced cancer care at 8 of our hospitals.
IHH Healthcare Bags Five Wins at the 15th Asian Excellence Awards
Celebrating our leadership, sustainability, and investor relations excellence on the regional stage.
Fortis CEO Shares Vision for a Healthier India on NDTV
Here is a look at how Fortis is contributing to India’s healthcare transformation.
IHH Singapore Hits New Digital and Imaging Milestones
Across Singapore, IHH Healthcare is transforming care delivery through data, technology and frontline innovation.
Lace Up for a Cause: Gleneagles JPMC Kicks Off Registration for World Heart Day Brunei Run 2025
On 4 June 2025, Gleneagles JPMC officially open registrations for World Heart Day Brunei Run 2025 to champion cardiovascular health awareness
Acibadem Achieves Top Honours in Türkiye’s 2025 Industry Rankings
Acıbadem Healthcare Group continues to solidify its leadership in Türkiye’s healthcare sector, earning prestigious accolades in two major 2025 industry surveys.
